CompletedNot Applicable

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

Egypt640 participantsStarted 2020-09-01

Plain-language summary

Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility Exclusion Criteria: * patients presenting more than 24 hours of symptoms onset * patients not eligible for PPCI program in our facility

What they're measuring

Number of participents with No reflow after PPCI and in hospital mortality

Timeframe: Within 48 hours from admission

Trial details

NCT IDNCT04785209

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-02-28

View on ClinicalTrials.gov More No-Reflow Phenomenon trials